Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Therma Bright Inc (TSV: THRM )

0.0150 +0.0050 (+50.00%)
Streaming Delayed Price Updated: 11:41 AM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 616,920
Open 0.0150
Bid (Size) 0.0100 (46,750)
Ask (Size) 0.0150 (34,490)
Prev. Close 0.0100
Today's Range 0.0150 - 0.0150
52wk Range 0.0050 - 0.0600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Therma Bright Announces Strategic Review & Update on Investment in Inretio
Toronto, Ontario--(Newsfile Corp. - March 21, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Therma Bright's Venowave Accepted for Review By Center for Medicare & Medicaid Services for Permanent CPT and HCPCS codes
Toronto, Ontario--(Newsfile Corp. - February 6, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer... 
Via Newsfile
Topics Supply Chain
Exposures Supply Chain

Performance

YTD
-40.00%
-40.00%
1 Month
+50.00%
+50.00%
3 Month
-25.00%
-25.00%
6 Month
-40.00%
-40.00%
1 Year
-75.00%
-75.00%

More News

Read More
Therma Bright Provides Update on Cease Trade Order
Via Newsfile
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Therma Bright Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States
Via Newsfile
Exposures Product Safety
Therma Bright Announces Amendments to InStatin & InVixa Acquisitions
Via Newsfile
Exposures COVID-19
Therma Bright Adds Hero LifeCare as Northeast Venowave Distribution Partner
Via Newsfile
Exposures Product Safety
Therma Bright Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description
Via Newsfile
Exposures Product Safety
Therma Bright Provides Update on Venowave's Permanent CPT/HCPCS Code Application Process
Via Newsfile
Exposures Product Safety
Therma Bright Provides Update on Venowave's Permanent CPT/HCPCS Codes and United States Distribution Partners
Via Newsfile
Therma Bright Provides Update on Venowave for the United States and Texas Region
Via Newsfile
Therma Bright Investigates Remote Therapeutic Monitoring (RTM) Reimbursement for its AI-Driven Digital Cough Technology
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Therma Bright's Investment Partner Inretio Announces Successful Completion of GLP Study for PREVA(TM) Thrombectomy Device
Via Newsfile
Therma Bright Expands U.S. Distribution of Venowave Device to Increase Sales Under Temporary CPT(R) & HCPCS Codes
Via Newsfile
Therma Bright Initiates Data Collection with AI Digital Cough Technology App at TB Clinics
Via Newsfile
Topics Artificial Intelligence Death
Exposures Artificial Intelligence COVID-19 Death
Therma Bright Milestone Payments Bring Ownership in Inretio to 7.5%
Via Newsfile
Therma Bright Secures Medicare and Medicaid Reimbursement for Venowave Device
Via Newsfile
Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Therma Bright's Investment Partner Inretio Moves to New Manufacturing Facility
Via Newsfile
Exposures Product Safety
Therma Bright Reports on Progress of Inretio's Novel Clot Removal Device for Stroke Treatment
Via Newsfile
Therma Bright Secures Exclusive License Agreement for AI4LYF's Patent-Pending Digital Cough Technology (DCT) to Detect Respiratory Diseases
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Therma Bright Inc. Invests in Ischemic Stroke Blood Clot Retriever Technology Company Inretio Inc. based in Israel
Via Newsfile
Exposures COVID-19
Therma Bright Provides 2022 Year End Update
Via Newsfile
Exposures COVID-19 Product Safety
Therma Bright Invests in the Development of Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)
Via Newsfile
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Therma Bright Inc. to Acquire an Exclusive License for a Patented Digital Cough Based Technology to Detect Respiratory Diseases
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19 Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.